{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444934764
| IUPAC_name = 2-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)guanidine
| image = Guanoxan.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2165-19-7
| ATC_prefix = C02
| ATC_suffix = CC03
| PubChem = 16564
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9V0MRL0R5Y
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 15704

<!--Chemical data-->
| C=10 | H=13 | N=3 | O=2 
| molecular_weight = 207.23 g/mol
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C10H13N3O2/c11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7/h1-4,7H,5-6H2,(H4,11,12,13)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = HIUVKVDQFXDZHU-UHFFFAOYSA-N
| smiles            = c1ccc2c(c1)OCC(O2)CNC(=N)N
}}

'''Guanoxan''' is a [[sympatholytic]] drug that was marketed as '''Envacar''' by Pfizer in the UK to treat [[hypertension|high blood pressure]]. It was not widely used and was eventually withdrawn from the market due to liver toxicity.<ref>{{cite book|last1=Broadley|first1=Kenneth J.|title=Autonomic Pharmacology|date=1996|publisher=CRC Press|isbn=9780748405565|page=276|url=https://books.google.com/books?id=nDvgZGMUOrkC&pg=PA276|language=en}}</ref><ref>{{cite book|last1=Wardell|first1=William M.|last2=Lasagna|first2=Louis|title=Regulation and drug development|date=1975|publisher=American Enterprise Institute for Public Policy Research|location=Washington|isbn=9780844731674|page=65}}</ref>

==References==
{{Reflist|2}}


{{Antihypertensives and diuretics}}
{{Monoamine reuptake inhibitors}}

[[Category:Guanidines]]
[[Category:Hepatotoxins]]
[[Category:Benzodioxins]]
[[Category:Withdrawn drugs]]


{{antihypertensive-stub}}